Palette Life Sciences AB
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Palette Life Sciences AB - overview
Established
2018
Location
Solna, -, Sweden
Primary Industry
Medical Devices & Equipment
About
Palette Life Sciences AB, located in Sweden, focuses on the development and commercialization of innovative medical solutions aimed at improving patient care and outcomes. Palette Life Sciences AB is dedicated to delivering advanced medical solutions. Founded in 2018 in Solna, Sweden, the company has engaged in four deals, with its most recent deal occurring on December 17, 2020. The latest funding round was a Trade Sale amounting to USD 650.
00 mn, with Teleflex Inc. as the investor. The total amount raised by the company is USD 650. 00 mn.
The CEO, Mathieu Petitjean, oversees the company’s strategic direction and operations. Palette Life Sciences AB specializes in innovative medical solutions that enhance patient care. The company offers a range of products aimed at improving clinical outcomes, including devices and treatment methods tailored to meet various medical needs. Their solutions are designed to address significant healthcare challenges, ensuring both effectiveness and safety in patient treatment.
For the year 2022, Palette Life Sciences AB reported a revenue of USD 35. 55 mn with an EBITDA of USD -28. 08 mn, reflecting the company's strategic investments in research and development to facilitate growth and innovation. Palette Life Sciences AB is focused on expanding its product line with upcoming medical innovations set for release in the near future.
The company aims to penetrate new markets in North America and Europe, establishing a stronger presence by 2025. The recent funding from the Trade Sale will support these initiatives, facilitating the development of new solutions and enhancing the company's market reach.
Current Investors
Genesis Care Pty Limited, Melker Schörling AB
Primary Industry
Medical Devices & Equipment
Sub Industries
Therapeutic Devices
Website
www.paletteab.com
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
Palette Life Sciences AB - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | Palette Life Sciences AB | - | ||||||||
| Private Debt | Completed | Palette Life Sciences AB | - | ||||||||
| Investment | Completed | Palette Life Sciences AB | - | ||||||||
| Add-on | Completed | Palette Life Sciences AB | - |
Displaying 1 - 4 of 4
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.